| scholarly article | Q13442814 |
| P50 | author | Aleksander S. Popel | Q1642695 |
| P2093 | author name string | Jeffery S Isenberg | |
| Hojjat Bazzazi | |||
| P2860 | cites work | Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells | Q85232367 |
| NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
| Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake | Q24302047 | ||
| Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1 | Q24310414 | ||
| Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases | Q24311877 | ||
| New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival | Q24336075 | ||
| The Reactome pathway knowledgebase | Q24567743 | ||
| Anti-VEGF Therapy and the Retina: An Update | Q26784605 | ||
| The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1 | Q28145820 | ||
| Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121) | Q28186833 | ||
| CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 | Q28251463 | ||
| Protein kinase C alpha activates RAF-1 by direct phosphorylation | Q28260100 | ||
| Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation | Q28510000 | ||
| Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium | Q28741586 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| Therapeutic angiogenesis for critical limb ischaemia | Q30456666 | ||
| Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism | Q30504482 | ||
| Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts | Q33312205 | ||
| Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury | Q33660552 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Angiogenesis in embryonic development--a review | Q33930024 | ||
| Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation | Q34275612 | ||
| CD47 signaling regulates the immunosuppressive activity of VEGF in T cells | Q34289358 | ||
| Endogenous angiogenesis inhibitors | Q34371061 | ||
| Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. | Q34385843 | ||
| Vascular endothelial growth factor a in intraocular vascular disease | Q34432428 | ||
| Autocrine VEGF signaling is required for vascular homeostasis | Q34443661 | ||
| Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition | Q34474189 | ||
| Rule-based modeling of biochemical systems with BioNetGen | Q34978140 | ||
| Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice. | Q35170952 | ||
| Targeting receptor tyrosine kinases and their downstream signaling with cell-penetrating peptides in human pulmonary artery smooth muscle and endothelial cells | Q35329940 | ||
| Molecular mechanism matters: Benefits of mechanistic computational models for drug development. | Q36052870 | ||
| Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). | Q36140753 | ||
| Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. | Q36223338 | ||
| Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation | Q36267274 | ||
| Annotating cancer variants and anti-cancer therapeutics in reactome | Q37017116 | ||
| A methodology for performing global uncertainty and sensitivity analysis in systems biology. | Q37197756 | ||
| Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation | Q37266304 | ||
| The role of vascular endothelial growth factor in wound healing | Q37308157 | ||
| Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies | Q37385797 | ||
| VEGF and angiopoietin signaling in tumor angiogenesis and metastasis | Q37863809 | ||
| Vascular endothelial growth factor and vascular homeostasis | Q37952670 | ||
| Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer | Q38332364 | ||
| Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. | Q39780346 | ||
| Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy | Q39981758 | ||
| Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole | Q40700817 | ||
| A mathematical model of T lymphocyte calcium dynamics derived from single transmembrane protein properties. | Q41858588 | ||
| Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects | Q41941549 | ||
| Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation | Q42380824 | ||
| VEGFR2 trafficking: speed doesn't kill | Q42574056 | ||
| Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output | Q43435823 | ||
| The complexity of cell signaling and the need for a new mechanics | Q44273211 | ||
| Ten years of anti-vascular endothelial growth factor therapy | Q46407140 | ||
| Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries | Q46926870 | ||
| A mathematical model of plasma membrane electrophysiology and calcium dynamics in vascular endothelial cells. | Q51017884 | ||
| Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 | ||
| Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation | Q58450934 | ||
| Specific inhibition of endothelial cell proliferation by thrombospondin | Q67666900 | ||
| Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis | Q79097312 | ||
| Signal transduction by vascular endothelial growth factor receptors | Q84520249 | ||
| P2507 | corrigendum / erratum | Corrigendum: Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation | Q42318042 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | in silico | Q192572 |
| P304 | page(s) | 48 | |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation | |
| P478 | volume | 8 |
| Q57467572 | Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides |
| Q55413755 | Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat. |
| Q92642755 | Endothelial Ca2+ Signaling, Angiogenesis and Vasculogenesis: just What It Takes to Make a Blood Vessel |
| Q50019794 | Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions |
| Q92891221 | Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma |
| Q88641629 | Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature |
| Q47234112 | Predictive model identifies strategies to enhance TSP1-mediated apoptosis signaling. |
| Q39438819 | Thrombospondins: A Role in Cardiovascular Disease |
| Q42318042 | Corrigendum: Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation | main subject | P921 |
Search more.